Skip to content
MarketScale
‹ Back to IndustriesSciences

On the Look-Out for Dry Eyes

Tears play a critical role in maintaining eye health beyond emotional expression, serving to lubricate and nourish the eye. Dry eye syndrome occurs when tear production or quality is insufficient, leading to discomfort and potential vision complications. Early detection and treatment are important for managing dry eye conditions effectively.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Featured ·
Share
On the Look-Out for Dry Eyes

Key takeaways

01

Tears are essential for eye lubrication, nourishment, and overall eye health — not just emotional responses.

02

Dry eye syndrome is a common condition caused by insufficient tear production or poor tear quality.

03

Regular eye check-ups and early intervention can help identify and manage dry eye symptoms before they worsen.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

For most of us, tears are associated solely with crying. In a moment of sadness or joy, we might shed a few tears–but otherwise, the curious water in our eyes is not something we typically worry about. Tears, as it turns out, are essential to maintaining eye health, helping to lubricate and nourish the eye with every blink. Insufficient tearing, however, can result in dry eye, a chronic issue that is becoming increasingly prevalent.

While it is particularly common in older adults, dry eye affects anyone whose body either does not produce enough tears, or simply produces poor quality tears. This may seem like a minor annoyance, but dry eye can lead to some serious complications. For instance, the tears you produce help clear away dirt or harmful particles from your eyes, and without this cleansing process, eye infections gain a foothold. Even barring infection, a lack of tears can lead to abrasion on the surface of the cornea, vision problems and even corneal ulcers

The rise in popularity of LASIK surgery has brought the condition of dry eye into prevalence. For the best surgical outcome, it is important to be able to detect and control dry eye prior to the procedure. Luckily, there are several tests to help detect this condition.

The Schirmer Test is perhaps the most straight forward as it involves placing a very thin strip of paper under the lower eyelid in order to measure tear production. In what is known as the “tear breakup time” (TBUT) test, a small amount of dye is placed in the eye to monitor tear distribution. For those concerned about tests that directly interact with the eye’s surface, a keratometer can be used to analyze the tear film through imaging. And rounding out our list of the more common tests for dry eye is MMP-9 Testing, which involves taking a small sample of tears from the bottom lid. It is quick and painless, providing results in minutes as to whether a patient is ready for LASIK or if further treatment is needed.

Luckily, dry eye is very treatable. It all comes down to managing the quantity of tears produced or drained from the eyes. If too few tears are produced, over-the-counter artificial tear solutions are available, or your doctor may prescribe higher strength eye drops if a larger increase in tear production is necessary. If, however, tears are being drained too quickly through the tear ducts, silicone plugs can be used to block the ducts so that moisture is kept in the eye longer. Finally, dietary supplements such as flaxseed oil or Omega-3 fatty acids are also helpful in treating this condition.

While dry eye certainly is more common in those over the age of 65, it is something everyone should be aware of, as it is often caused by allergic reactions or even a medication you may be taking for an entirely different condition.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

F
Featured

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

F
Featured

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512